The Global Coagulation Testing Market is expected to reach a revenue value of $3566.0 Mn by 2026, at a CAGR of 5.9% in the forecast period.
Market Introduction and Overview
In recent years, blood coagulation monitoring has become crucial to diagnosing causes of haemorrhages, developing anticoagulant drugs, assessing bleeding risk in extensive surgery procedures and dialysis, and investigating the efficacy of haemostatic therapies. In this regard, advanced technologies such as microfluidics, fluorescent microscopy, electrochemical sensing, photo acoustic detection, and micro/Nano electromechanical systems (MEMS/NEMS) have been employed to develop highly accurate, robust, and cost-effective point of care (POC) devices. With increasing prevalence of haemostatic diseases, the demand for blood coagulation testing has increased. To analyse the treatment efficiency against haemostatic diseases, the blood clotting tests are required.
The liver plays an important role in the normal functioning of haemostasis, which helps in preventing bleeding and undue activation of coagulation. Liver cancer is the sixth most common-incident cancer globally and the fourth most common cause of cancer death. According to WHO, the mortality rate due to liver cancer was about 11.4% globally in the year 2020. Moreover, advancements in technology for blood coagulation tests is fuelling the market growth. Furthermore, increasing prevalence of liver diseases, thrombophilia, and haemophilia are also augmenting the market growth.
Emphasis on the mechanisms of the blood coagulation measurements with different technologies in order to provide an insight to researchers on advantages of certain techniques in detecting disorders, future trends for clinical monitoring and treatments are the associating key factors for the market to grow. Moreover, the role of Nano materials for both detection and treatment, available commercial devices, artificial intelligence in diagnosis, and monitoring for higher accuracy of measurements are also contributing in boosting the market demand. However, availability of expensive treatment and poor reimbursement policies in the developing regions of the world are some of the factors, which may hamper the market growth during the forecast period.
The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in the Coagulation Testing Market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges. The report has profiled eighteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.
Global Coagulation Testing Market Segment Analysis
By test type, the Prothrombin time (PT) test segment is expected to grow at a significant pace. The segment is expected to generate a revenue value of $2475.5 Mn by 2026, at a CAGR of 5.5%.These tests are used to monitor safety and effectiveness of anticoagulants, and sensitive to the lack of many coagulation factors. PT test is used to investigate clotting blood from extrinsic and common pathways in which factors I (Fibrinogen), II (Prothrombin), V, VII and X contribute. APTT test is measuring clotting from intrinsic and common pathways.
Short measurement durations as compared to conventional coagulation tests and their use in pre-hospital emergency services to provide fast and reliable results for patients are key drivers to the market. By end-use, the hospital segment is expected to register a CAGR of 5.6% during the forecast period holding an expected revenue value of $1290.9Mnin the Coagulation Testing Market. Surgeries and other operations are performed majorly in hospitals, due to availability of all tools and technologies required.
Testing procedures conducted in hospitals or hospital-attached outpatient facilities enable ease of handling any emergency situations that may arise.Rapid expansion of hospitals coupled with availability of analysers and consumables based on hospital needs is also expanding the segment. Global Coagulation Testing Market
To know about the Research Methodology :- Request Free Sample Report
Global Coagulation Testing Market Regional Insights Global Coagulation Testing Market1
North America and Europe are expected to increase the market for coagulation testing in the forecast period. US, UK and Germany are show high adoption rates of instruments such as PT monitors, PT Testing, rising awareness among people and increase in cardiovascular diseases is boosting the market in NA. Europe region is focusing more on the advanced innovations and excellent strategies are anticipated to drive the European Market growth. The number of CVD (Cardiovascular disease) cases has increased in Europe mainly due to rise in the fat consumption.
In addition, levels of obesity are high across Europe in both adults and children. These health issues are expected to drive the market growth in the European region. The Asia Pacific market was valued $358.1 Mn in 2016. The market valuation is expected to reach $891.8 Mn by 2025. It is expected to witness significant growth of xx% during the forecast period due to the increasing cardiovascular disorder cases. The allocation of a large amount of healthcare expenditure for hospitals and dispensing medicines to the elderly is expected drive the market demand.
The report also helps in understanding Global Coagulation Testing Market dynamics, structure by analysing the market segments and project the Global Coagulation Testing Marketsize. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Coagulation Testing Marketmake the report investor’s guide
For More Information Visit :https://www.maximizemarketresearch.com/market-report/global-coagulation-...
Scope of the Report Global Coagulation Testing Market: Inquire before Buying
Global Coagulation Testing Market2
Global Coagulation Testing Market, By Region
• North America
• South America
• Asia Pacific
Key Players Operating in the Global Coagulation Testing Market
• Alere INC
• F. Hoffmann-La Roche Ltd
• Abbott Laboratories
• Siemens Healthcare
• SYSMEX Corporation
• Universal Biosensors, INC
• Hemosonics LLC
• Helena Laboratories, INC
• Sekisui Medical Co. LTD
• Tcoag Ireland LTD
• Micro point Biosciences
• Thermo Fisher Scientific, INC
• NIHON KOHDEN Corporation
• Sysmex Corporation
• Danaher Corporation
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.